Hormones, lymphohemopoietic cytokines and the neuroimmune axis

Comparative Biochemistry and Physiology - A Physiology

Volumn 116, Issue 3, 1997, Pages 183-201

  Johnson, R W ^a   Arkins, S ^b   Dantzer, R ^c   Kelley, K W ^a  

^a UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

^b ILLINOIS STATE UNIVERSITY   (United States)

^c INSERM   (France)

Author keywords

endocrine immune interactions; growth hormone; hematopoiesis; insulin like growth factor

Indexed keywords

CYTOKINE; GROWTH HORMONE; HORMONE; LIPOPOLYSACCHARIDE; PROLACTIN; PROTEIN TYROSINE KINASE; RECOMBINANT GROWTH HORMONE; SOMATOMEDIN C; TUMOR NECROSIS FACTOR ALPHA;

CONFERENCE PAPER; GROWTH HORMONE DEFICIENCY; HEMATOPOIESIS; HORMONE RELEASE; HUMAN; LEUKOCYTE ACTIVATION; NEUROIMMUNOLOGY; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; CYTOKINES; HEMATOPOIESIS; HORMONES; IMMUNE SYSTEM; LYMPHOCYTES; NERVOUS SYSTEM PHYSIOLOGY;

EID: 0031104633     PISSN: 03009629     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0300-9629(96)00277-0     Document Type: Conference Paper

References (222)

1. Abboud S.L., Bethel C.R., Aron D.C. Secretion of insulinlike growth factor I and insulinlike growth factor-binding proteins by murine bone marrow stromal cells. J. Clin. Invest. 88:1991;470-475.
2. Andus T., Bauer J., Gerok W. Effects of Cytokines on the liver. Hepatology. 13:1991;364-375.
3. Araki E., Lipes M.A., Patti M.-E., Brüning J.C., Haag B. III, Johnson R.S., Kahn C.R. Alternative pathway of insulin signalling in mice with targeted disruption of the IRS-1 gene. Nature. 372:1994;186-190.
4. Argetsinger L.S., Campbell G.S., Yang X., Witthuhn B.A., Silvenoinen O., Ihle J.N., Carter-Su C. Identification of Jak2 as a growth hormone receptor-associated tyrosine kinase. Cell. 74:1993;237-244.
5. Argetsinger L.S., Hsu G.W., Myers M.G. Jr., Billestrup N., White M.F., Carter-Su C. Growth hormone, interferon-γ, and leukemia inhibitory factor promoted tyrosyl phosphorylation of insulin receptor substrate-1. J. Biol. Chem. 270:1995;14685-14692.
6. Arkins S., Dantzer R., Kelley K.W. Somatolactogens, somatomedins and immunity. J. Dairy Sci. 76:1993;2437-2450.
7. Arkins S., Rebeiz N., Biragyn A., Reese D.L., Kelley K.W. Murine macrophages express abundant IGF-I class I, Ea and Eb transcripts. Endocrinology. 133:1993;2334-2343.
8. Arkins S., Rebeiz N., Brunke-Reese D.L., Minshall C., Kelly K.W. The colony stimulating factors induce expression of insulin-like growth factor-I messenger ribonucleic acid during hematopoiesis. Endocrinology. 136:1995;1153-1160.
9. Arkins S., Rebeiz N., Brunke-Reese D.L., Biragyn A., Kelley K.W. Interferon-gamma inhibits macrophage insulin-like growth factor-I synthesis at the transcriptional level. Mol. Endocrinol. 9:1995;350-360.
10. Ban E., Milon G., Prudhomme N., Fillion G., Haour F. Receptors for interleukin-1 (α and β) in mouse brain. mapping and neuronal localization in hippocampus Neuroscience. 43:1991;21-30.
11. Ban E., Haour F., Lenstra R. Brain interleukin 1 gene expression induced by peripheral lipopolysaccharide administration. Cytokine. 4:1992;48-54.
12. Banks W.A., Kastin A.J. The interleukins-1α, -1β and -2 do not acutely disrupt the murine blood-brain barrier. Int. J. Immunopharmacol. 14:1992;629-636.
13. Banks W.A., Kastin A.J., Gutierrez E.G. Interleukin-1α in blood has direct access to cortical brain cells. Neurosci. Lett. 163:1993;41-44.
14. Banks W.A., Ortiz L., Plotkin S.R., Kastin A.J. Human interleukin (IL) 1α, murine IL-1α and murine IL-1β are transported from blood to brain in the mouse by a shared saturable mechanism. J. Pharmacol. Exp. Ther. 259:1991;988-996.
15. Bank W.A., Kastin A.J., Gutierrez E.G. Penetration of interleukin-6 across the murine blood-brain barrier. Neurosci. Lett. 179:1994;53-56.
16. Baserga R. Oncogenes and the strategy of growth factors. Cell. 79:1994;927-930.
17. Bazan J.F. Structural design and molecular evolution of a cytokine receptor superfamily. Proc. Natl. Acad. Sci. USA. 87:1990;6934-6938.
18. Bellone G., Geuna M., Carbone A., Silvestri S., Foa R., Emanuelli G., Matera L. Regulatory action of prolactin on the in vitro growth of CD34+ve human hemopoietic progenitor cells. J. Cell. Physiol. 163:1995;221-231.
19. Benveniste E.N. Inflammatory cytokines within the central nervous system. sources, function, and mechanism of action Am. J. Physiol. 263:1992;C1-C16.
20. Berczi I. The role of the growth and lactogenic hormone family in immune function. Neuroimmunomodulation. 1:1994;201-216.
21. Berczi I., Nagy E. Effects of hypophysectomy on immune function. Ader R., Cohen N., Felton D. Psychoneuroimmunology II. 1991;339-376 Academic Press, San Diego, CA.
22. Berkenbosch F., van Oers J., Del Rey A., Tilders F., Besedovsky H.O. Corticotropin-releasing factor-producing neurons in the rat activated by interleukin-1. Science. 238:1987;524-526.
23. Besedovsky H.O., Sorkin E., Keller M., Muller J. Changes in blood hormone levels during the immune response. Proc. Soc. Exp. Biol. Med. 150:1975;466-470.
24. Besedovsky H.O., Del Ray A.E., Sorkin E. Lymphokine-containing supernatants from Con A-stimulated cells increase corticosterone blood levels. J. Immunol. 126:1981;385-387.
25. Beutler B., Cerami A. The biology of cachectin/TNF - a primary mediator of the host response. Ann. Rev. Immunol. 7:1989;625-655.
26. Binz K., Joller P., Froesch P., Binz H., Zapf J., Froesch E.R. Repopulation of atrophied thymus in diabetic rats by insulin-like growth factor I. Proc. Natl. Acad. Sci. USA. 87:1990;3690-3694.
27. Blalock J.E. The syntax of immune-neuroendocrine communication. Immunol. Today. 15:1994;504-511.
28. Blalock J.E. The immune system. Our sixth sense. The Immunologist. 2:1994;8-15.
29. Blatteis C.M. Neuromodulative actions of cytokines. Yale J. Biol. Med. 63:1990;133-146.
30. Blatteis C.M. The OVLT. The interface between the brain and circulating pyrogens? Bartfai T, Ottoson D. Neuroimmunology of Fever. 1992;167 Pergamon, Oxford.
31. Bluthé R.M., Pawloski M., Suarez S., Parnet P., Pittman Q., Kelley K.W., Dantzer R. Synergy between tumor necrosis factor α and interleukin 1 in the induction of sickness behavior in mice. Psychoneuroendocrinology. 19:1994;197-207.
32. Bluthé R.M., Beaudu C., Kelley K.W., Dantzer R. Differential effects of IL-1ra on sickness behavior and weight loss induced by IL-1 in rats. Brain Res. 677:1995;171-176.
33. Bluthé R.M., Walter V., Parnet P., Layé S., Lestage J., Verrier D., Poole S., Stenning B.E., Kelley K.W., Dantzer R. Lipopolysaccharide induces sickness behaviour in rats by a vagal mediated mechanism. C.R. Acad. Sci. Paris. 317:1994;499-503.
34. Boyer S.H., Bishop T.R., Rogers O.C., Noyes A.N., Frelin L.P., Hobbs S. Roles of erythropoietin, insulin-like growth factor-I and undifferentiated serum factors in promoting maturation of purified murine erythroid colony-forming units. Blood. 80:1992;2503-2512.
35. Brown S.L., Smith L.R., Blalock J.E. Interleukin-1 and interleukin-2 enhance proopiomelanocortin gene expression in pituitary cells. J. Immunol. 139:1987;3181-3183.
36. Burgering B.M., Coffer P.J. Protein kinase B (c-Akt) in phosphatidylinositol-3-OH kinase signal transduction. Nature. 376:1995;599-602.
37. Carter D.B., Deibel M.R., Dunn C.J., Tomich C.S., Laborde A.L., Slightom J.L., Berger A.E., Bienkowski M.J., Sun F.F., McEwan R.N., Harris P.K., Yem A.W., Waszak G.A., Chosay J.G., Sieu L.C., Hardee M.M., Zurcher-Neely H.A., Reardon I.M., Heinrikson R.L., Truesdell S.E., Shelly J.A., Eessalu T.E., Taylor B.M., Tracey D.E. Purification, cloning, expression and biological characterization of an interleukin-1 receptor antagonist protein. Nature. 344:1990;633-638.
38. Cheatham B., Kahn C.R. Insulin action and the insulin signaling network. Endocr. Rev. 16:1995;117-142.
39. Cheatham B., Vlaos C.J., Cheatham L., Wang L., Blenis J., Kahn C.R. Phosphatidylinositol 3-kinase activation is required for insulin stimulation of pp70 S6 kinase, DNA synthesis, and glucose transporter translocation. Mol. Cell. Biol. 14:1994;4902-4911.
40. Chizzonite R., Truitt T., Kilian P.L., Stern A.S., Nunes P., Parker K.P., Kaffka K.L., Chua A.O., Lugg D.K., Gubler U. Two high-affinity interleukin 1 receptors represent separate gene products. Proc. Natl. Acad. Sci. USA. 86:1989;8029-8033.
41. Clark R., Strasser J., McCabe S., Robbins K., Jardieu P. Insulin-like growth factor-I stimulation of lymphopoiesis. J. Clin. Invest. 92:1993;540-548.
42. Colotta F., Re F., Muzio M., Bertini R., Polentarutti N., Sironi M., Giri J.G., Dower S.K., Sims J.E., Mantovani A. Interleukin-1 type II receptor. a decoy target for IL-1 that is regulated by IL-4 Science. 261:1993;472-475.
43. Cope A.P., Aderka D., Wallach D., Kahan M., Chu N.R., Brennan F.M., Feldmann M. Soluble TNF receptor production by activated T lymphocytes. differential effects of acute and chronic exposure to TNF Immunology. 84:1995;21-30.
44. Corpas E., Harman S.M., Blackman M.R. Human growth hormone and human aging. Endocr. Rev. 14:1993;20-39.
45. Dahn M.S., Lange P., Jacobs L.A. Insulin like growth factor-I production is inhibited in human sepsis. Arch. Surg. 123:1988;1409-1414.
46. Dainiak N. control of hematopoietic cell growth by somatomedins. Exp. Hematol. 21:1993;1405-1407.
47. Dantzer R. How do cytokines say hello to the brain? Neural versus humoral mediation. Eur. Cytokine Net. 5:1994;271-273.
48. Davila D.R., Edwards C.K.E. III, Arkins S., Simon J., Kelley K.W. Interferon-γ-induced priming for secretion of superoxide anion and tumor necrosis factor-α declines in macrophages from aged rats. FASEB Journal. 4:1990;2906-2911.
49. Dinarello C.A. Interleukin-1 and interleukin-1 antagonism. Blood. 77:1991;1627-1652.
50. Dinarello C.A. Biology of interleukin-1. FASEB J. 2:1988;108-115.
51. Downward J. A target for PI(3) kinase. Nature. 376:1995;553-554.
52. Ebisui O., Fukata J., Murakami N., Kobayashi H., Segawa H., Muro S., Hanaoka I., Naito Y., Masui Y., Ohmoto Y., Imura H., Nakao K. Effect of IL-1 receptor antagonist and antiserum to TNF-α on LPS-induced plasma ACTH and corticosterone rise in rats. Am. J. Physiol. 266:1994;E986-E992.
53. Edwards C.K. III, Lorence R.M., Dunham D.M., Arkins S., Yunger L.M., Greager J.A., Walter R.J., Dantzer R., Kelley K.W. Hypophysectomy inhibits the synthesis of tumor necrosis factor α by rat macrophages. partial restoration by exogenous growth hormone or interferon γ Endocrinology. 128:1991;989-996.
54. Edwards C.K. III, Yunger L.M., Lorence R.M., Dantzer R., Kelley K.W. The pituitary gland is required for protection against lethal effects of Salmonella typhimurium. Proc. Natl. Acad. Sci. USA. 88:1991;2274-2277.
55. Edwards C.K. III, Ghiasuddin S.M., Yunger L.M., Lorence R.M., Arkins S., Dantzer R., Kelley K.W. In vivo administration of recombinant growth hormone or interferon-γ activates macrophages; enhanced resistance to experimental Salmonella typhimurium infection is correlated with the generation of reactive oxygen intermediates. Infection and Immunity. 60:1992;2514-2521.
56. Edwards C.K. III, Arkins S., Yunger L.M., Blum A., Dantzer R., Kelley K.W. The macrophage-activating properties of growth hormone. Cell. Mol. Neurobiol. 12:1992;499-510.
57. Edwards C.K. III, Ghiasuddin S.M., Schepper J.M., Yunger L.M., Kelley K.W. A newly defined property of somatotropin. priming of macrophages for production of superoxide anion Science. 239:1988;769-771.
58. Eisenberg S.P., Evans R.J., Arend W.P., Verderber E., Brewer M.T., Hannum C.H., Thompson R.C. Primary structure and functional expression from complementary DNA of a human interleukin-1 receptor antagonist. Nature. 343:1990;341-346.
59. Engelmann H.D., Aderka M., Rubinstein M., Rotman D., Wallach D. A tumor necrosis factor-binding protein purified to homogeneity from human urine protects cells from tumor necrosis factor toxicity. J. Biol. Chem. 264:1989;11974-11980.
60. Everaerdt B., Brouckaert P., Fiers W. Recombinant IL-1 receptor antagonist protects against TNF-induced lethality in mice. J. Immunol. 152:1994;5041-5049.
61. Fairbairn L.J., Cowling G.J., Reipert B.M., Dexter T.M. Suppression of apoptosis allows differentiation and development of a multipotent hemopoietic cell line in the absence of added growth factors. Cell. 74:1993;823-832.
62. Fan J., Molina P.E., Gelato M.C., Lang C.H. Differential tissue regulation of insulin-like growth factor-I content and binding proteins after endotoxin. Endocrinology. 134:1994;1685-1692.
63. Farrar W.L., Kilian P.L., Ruff M.R., Hill J.M., Pert C.B. Visualization and characterization of interleukin 1 receptors in brain. J. Immunol. 139:1987;459-463.
64. Feingold K.R., Grunfeld C. Tumor necrosis factor alpha stimulates hepatic lipogenesis in the rat in vivo. J. Clin. Invest. 193:1987;318-325.
65. Fent K., Zbinden G. Toxicity of interferon and interleukin. Trends Pharmacol. Sci. 8:1987;100-105.
66. Fleisher T.A., White R.M., Broder S., Nissley P., Blaese R.M., Mulvihill J.J., Olive G., Waldman T.A. X-linked hypogammaglobulinemia and isolated growth hormone deficiency. N. Engl. J. Med. 302:1980;1429-1434.
67. Fontana A., Bodmer S., Frei K. Immunoregulatory factors secreted by astrocytes and glioblastoma cells. Lymphokines. 14:1987;91-121.
68. Frei K., Nadal D., Ralph P., Fontana A. Cytokines in inflammatory brain diseases. Cellular and cytokine networks in tissue immunity. 1991;Wiley-Liss, New York. 91-98.
69. French R., Zachary J.F., Dantzer R., Frawley L.S., Chizzonite R., Parnet P., Kelley K.W. Dual expression of p80 type I and p68 type II interleukin-I receptors on anterior pituitary cells synthesizing growth hormone. Endocrinology. 137:1996;4027-4036.
70. Freund G.G., Kulas D.T., Mooney R.A. Insulin and IGF-I increase mitogenesis and glucose metabolism in the multiple myeloma cell line, RPMI 8226. J. Immunol. 151:1993;1811-1820.
71. Fu Y.K., Arkins S., Wang B.S., Kelley K.W. A novel role of growth hormone and insulin-like growth factor. Priming neutrophils for superoxide anion secretion J. Immunol. 146:1991;1602-1608.
72. Fu Y.K., Arkins S., Fuh G., Cunningham B.C., Wells J.A., Fong S., Cronin M.J., Dantzer R., Kelley K.W. Growth hormone augments superoxide anion secretion of human neutrophils by binding to the prolactin receptor. J. Clin. Invest. 89:1992;451-457.
73. Fu Y.-K., Arkins S., Li Y.M., Dantzer R., Kelley K.W. Reduction in superoxide anion secretion and bactericidal activity of neutrophils from aged rats. reversal by the combination of gamma interferon and growth hormone Infection and Immunity. 62:1994;1-8.
74. Fukata J., Usui Y., Nakai Y., Imura H. Effects of recombinant human interleukin-1α, -1β, -2 and -6 on ACTH synthesis and release in the mouse pituitary tumor line AtT-20. J. Endocrinol. 122:1989;33-39.
75. Gatti S., Bartfai T. Induction of tumor necrosis factor-alpha messenger RNA in the brain after peripheral endotoxin treatment-comparison with interleukin-1 family and interleukin-6. Brain Res. 624:1993;291-294.
76. Geenen V., Achour I., Robert F., Vandersmissen E., Sodoyez J.C., Defresne M.P., Boniver J., Lefebvre P.J., Franchimont P. Evidence that insulin-like growth factor 2 (IGF-2) is the dominant thymic peptide of the insulin superfamily. Thymus. 21:1993;115-127.
77. Gibson L.F., Piktel D., Landreth K.S. Insulin-like growth factor-I potentiates expansion of interleukin-7 dependent pro-B cells. Blood. 82:1993;3005-3011.
78. Gjerset R.A., Yeatgin J., Volkman S.K., Vila V., Arya J., Haas M. Insulin-like growth factor-I supports proliferation of autocrine thymic lymphoma cells with a pre-T cell phenotype. J. Immunol. 145:1990;3497-3501.
79. Golde D.W., Bersh N., Li C.H. Growth hormone. species specific stimulation of erythropoiesis in vitro Science. 196:1977;1112-1113.
80. Goodwin R.G., Anderson D., Jerzy R., Davis T., Brannan C.I., Copeland N.G., Jenkins N.A., Smith C.A. Molecular cloning and expression of the type 1 and type 2 murine receptors for tumor necrosis factor. Mol. Cell. Biol. 11:1991;3020-3026.
81. Gray P.W., Barrett K., Chantry D., Truner M., Feldman M. Cloning of human tumor necrosis factor (TNF) receptor cDNA and expression of recombinant soluble TNF-binding protein. Proc. Natl. Acad. Sci. USA. 87:1990;7380-7384.
82. Grunfeld C., Feingold K.R. Tumor necrosis factor, cytokines, and hyperlipidemia of infection. Trend Endocrinol. Met. 2:1991;213-219.
83. Grunfeld C., Palladino M.A. Tumor necrosis factor. immunologic, antitumor, metabolic, and cardiovascular activities Adv. Intern. Med. 35:1990;45-72.
84. Guler H.P., Zapf J., Scheiwiller E., Froesch E.R. Recombinant human insulin-like growth factor I stimulates growth and has distinct effects on organ size in hypophysectomized rats. Proc. Natl. Acad. Sci. USA. 85:1988;4889-4893.
85. Gustafson T.A., He W., Craparo A., Schaub C.D., O'Neill T.J. Phosphotyrosine-dependent interaction of SHC and insulin receptor substrate 1 with the NPEY motif of the insulin receptor via a novel non-SH2 domain. Mol. Cell. Biol. 15:1995;2500-2508.
86. Gutierrez E.G., Banks W.A., Kastin A.J. Murine tumor necrosis factor alpha is transported from blood to brain in the mouse. J. Neuroimmunol. 47:1993;169-176.
87. Haour F.G., Ban E.M., Milon G.M., Baran D., Fillion G.M. Brain interleukin 1 receptors. Characterization and modulation after lipopolysaccharide injection Prog. NeuroendocrinImmunology. 3:1991;196-204.
88. Hill M.R., McCallum R.E. Identification of tumor necrosis factor as a transcriptional regulator of the phosphoenolpyruvate carboxykinase gene following endotoxin treatment in mice. Infect. Immunol. 60:1992;4040-4050.
89. Hirai K., Miyamasu M., Yamaguchi M., Nakajima K., Ohtoshi T., Koshino T., Takaishi T., Morita Y., Ito K. Modulation of human basophil histamine release by insulin-like growth factors. J. Immunol. 150:1993;1503-1508.
90. Hochberg Z., Hertz P., Maor G., Oiknine J., Aviram M. Growth hormone and insulin-like growth factor-I increase macrophage uptake and degradation of low density lipoprotein. Endocrinology. 131:1992;430-435.
91. Hooghe-Peters E.L., Hooghe R. Growth hormone, prolactin and IGF-I as lymphohemopoietic cytokines. 1995;R.G. Landes Company, Austin, TX.
92. Hopkins S.J., Rothwell N.J. Cytokines and the nervous system I. expression and recognition Trends Neurosci. 18:1995;83-88.
93. Janský L., Vybiral S., Pospišilova D., Roth J., Zeisberger E., Kaminková J. Production of systemic and hypothalamic cytokines during the early phase of endotoxin fever. Neuroendocrinology. 62:1995;55-61.
94. Jardieu P., Clark R., Mortensen D., Dorshkind K. In vivo administration of insulin-like growth factor-I stimulates primary B lymphopoiesis and enhances lymphocyte recovery after bone marrow transplantation. J. Immunol. 152:1994;4320-4327.
95. Jirillo E., Covelli V., Maffione A.B., Greco B., Pece S., Fumarola D., Antonaci S., De Simone C. Endotoxins, cytokines, and neuroimmune networks with special reference to HIV infection. Ann. N.Y. Acad. Sci. 741:1994;174-184.
96. Johnson E.W., Jones L.A., Kozak R.W. Expression and function of insulin-like growth factor receptors on anti-CD3-activated human T lymphocytes. J. Immunol. 148:1992;63-71.
97. Jones J.I., Clemmons D.R. Insulin-like growth factors and their binding proteins. biological actions Endocr. Rev. 16:1995;3-34.
98. Kakucska I., Qi Y., Clark B.D., Lechan R.M. Endotoxin-induced corticortropin-releasing hormone gene expression is the hypothalamic paraventricular nucleus is mediated centrally by interleukin-1. Endocrinology. 133:1993;815-821.
99. Kasting N.W., Martin J.B. Altered release of growth hormone and the thyrotropin induced by endotoxin in the rat. Am. J. Physiol. 243:1982;E332-E337.
100. Katsuura G., Arimura A., Koves K., Gottschall P.E. Involvement of organum vasculosum of lamina terminalis and preoptic area in interleukin 1β-induced ACTH release. Am. J. Physiol. 258:1990;E163-E171.
101. Keegan A.D., Nelms K., White M., Wang L.-M., Pierce J.H., Paul W.E. An IL-4 receptor region containing an insulin receptor motif is important for IL-4-mediated IRS-1 phosphorylation and cell growth. Cell. 76:1994;811-820.
102. Kelley K.W., Arkins S., Li Y.M. Growth hormone, prolactin, and insulin-like growth factor. new jobs for old players Brain Behav. Immun. 6:1992;317-326.
103. 3 pituitary adenoma implants can reverse thymic aging. Proc. Natl. Acad. Sci. USA. 83:1986;5663-5667.
104. Kelley K.W. Growth hormone, lymphocytes and macrophages. Biochem. Pharmacol. 38:1989;705-713.
105. Kelley, K.W.; Arkins, S.; Minshall, C.; Liu, Q.; Dantzer, R. Growth hormone, growth factors and hematopoiesis. Horm. Res. (In Press).
106. Kent S., Rodriguez F., Kelley K.W., Dantzer R. Anorexia induced by microinjection of IL-1β in the ventromedial hypothalamus of the rat. Physiol. Behav. 56:1994;1031-1036.
107. Kent S., Bluthé R.M., Kelley K.W., Dantzer R. Sickness behavior as a new target for drug development. Trends Pharmacol. Sci. 131:1992;24-28.
108. Kent S., Bluthé R.M., Dantzer R., Hardwick A.J., Kelley K.W., Rothwell N.J., Vannice J.L. Different receptor mechanisms mediate the pyrogenic and behavioral effects of interleukin 1. Proc. Natl. Acad. Sci. USA. 89:1992;9117-9120.
109. Kimata H., Fujimoto M. Growth hormone and insulin-like growth factor-I induce immunoglobulin (Ig)E and IgG4 production by human B cells. J. Exp. Med. 180:1994;727-732.
110. Kincade P.W. B lymphopoiesis. global factors, local control Proc. Natl. Acad. Sci. USA. 91:1994;2888-2889.
111. Kinouchi K., Brown G., Pasternak G., Donner D.B. Identification and characterization of receptors for tumor necrosis factor-α in the brain. Biochem. Biophys. Res. Comm. 181:1991;1532-1538.
112. Kishimoto T., Taga T., Akira S. Cytokine signal transduction. Cell. 76:1994;253-262.
113. Klasing K.C. Nutritional aspects of leukocytic cytokines. J. Nutr. 118:1988;1436-1446.
114. Kluger M.J. Fever. role of pyrogens and cryogens Physiol. Rev. 71:1991;93-127.
115. Knyszynski A., Adler-Kunin S., Globerson A. Effects of growth hormone on thymocyte development from progenitor cells in the bone marrow. Brain Behav. Immun. 6:1992;327-340.
116. Kohno T., Brewer M.T., Baker S.L., Schwartz P.E., King M.W., Hale K.K., Squires C.H., Thompson R.C., Vannice J.L. A second tumor necrosis factor receptor gene product can shed a naturally occurring tumor necrosis factor inhibitor. Proc. Natl. Acad. Sci. USA. 87:1990;8331-8335.
117. Kooijman R., Lauf J.J., Kappers A.C., Rijkers G.T. Insulin-like growth factor induces phosphorylation of immunoreactive insulin receptor substrate and its association with phosphatidylinositol-3 kinase in human thymocytes. J. Exp. Med. 182:1995;593-597.
118. Kurtz A., Zapf J., Eckardt K.-U., Clemons G., Froesch E.R., Bauer C. Insulin-like growth factor I stimulates erythropoiesis in hypophysectomized rats. Proc. Natl. Acad. Sci. USA. 85:1988;7825-7829.
119. Landreth K.S., Narayanan R., Dorshkind K. Insulin-like growth factor-I regulates pro-B cell differentiation. Blood. 80:1992;1207-1212.
120. Layé S., Bluthé R., Kent S., Combe C., Médina C., Parnet P., Kelley K.W., Dantzer R. Subdiaphragmatic vagotomy blocks induction of IL-1β mRNA in mice brain in response to peripheral LPS. Am. J. Physiol. 268:1995;R1327-R1331.
121. Layé S., Parnet P., Goujon E., Dantzer R. Peripheral administration of lipopolysaccharide induces the expression of cytokine transcripts in the brain and pituitary of mice. Mol. Brain Res. 27:1994;157-162.
122. Lazarus D.D., Lowry S.F., Moldawer L.L. Cytokines acutely decrease circulating insulin-like growth factor-I (IGF-I) and IGF binding protein-3 (IGFBP-3). Archiv. Surg. 129:1992;92-94.
123. LeRoith D., Werner H., Beitner-Johnson D., Roberts C.J. Jr. Molecular and cellular aspects of the insulin-like growth factor I receptor. Endocr. Rev. 16:1995;143-163.
124. Li, Y.M.; Arkins, S.; McCusker, R.H., Jr.; Donovan, S.M.; Liu, Q.; Jayaraman, S.; Dantzer, R.; Kelley, K.W. Macrophages synthesize and secrete a 25 KDa protein that binds insulin-like growth factor-I. J. Immunol. (Accepted, pending revision).
125. Lienhard G.E. Life without the IRS. Nature. 372:1994;128-129.
126. Lin T., Wang D., Nagpal M.L., Chang W., Calkins J.H. Down-regulation of Leydig cell insulin-like growth factor-I gene expression by interleukin-I. Endocrinology. 130:1992;1217-1224.
127. Ling P.R., Istfan N.W., Colon E., Bistrian B.R. Differential effects of interleukin-1 receptor antagonist in cytokine-and endotoxin-treated rats. Am. J. Physiol. 268:1995;E255-E261.
128. Linthorst A.C.E., Flachskamm C., Holsboer F., Reul J.M.H.M. Local administration of recombinant human interleukin-1β in the rat hippocampus increases serotonergic neurotransmission, hypothalamic-pituitary-adrenocortical axis activity, and body temperature. Endocrinology. 135:1994;520-532.
129. Liu Q., Arkins S., Biragyn A., Minshall C., Parnet P., Dantzer R., Kelley K.W. Competitive reverse transcriptase-polymerase chain reaction using a synthetic internal RNA standard to quantitate transcripts for leukocyte-derived hormones. Neuroimmunomodulation. 1:1994;33-41.
130. Loetscher H., Pan Y.C., Lahm H.W., Brockhaus M., Lesslauer W. Molecular cloning and expression of the human 55 kd tumor necrosis factor receptor. Cell. 61:1990;351-359.
131. Martin S.J., Green D.R. Protease activation during apoptosis. death by a thousand cuts? Cell. 82:1995;349-352.
132. McCarthy D.O., Daun J.M. The role of prostaglandins in interleukin-1 induced gastroparesis. Physiol. Behav. 52:1992;351-353.
133. McCubrey J.A., Steelman L.S., Mayo M.W., Algate P.A., Dellow R.A., Kaleko M. Growth promoting effects of insulin-like growth factor-I (IGF-I) on hematopoietic cells. overexpression of introduced IGF-I receptor abrogates interleukin-3 dependency of murine factor-dependent cells by a ligand-dependent mechanism Blood. 78:1991;921-929.
134. McMahan C.J., Slack J.L., Mosley B., Cosman D., Lupton S.D., Brunton L.L., Grubin C.E., Wignall J.M., Jenkins N.A., Brannan C.I., Copeland N.G., Huebner K., Croce C.M., Cannizzarro L.A., Benjamin D., Dower S.K., Spriggs M.K., Sims J.E. A novel IL-1 receptor, cloned from B cells by mammalian expression, is expressed in many cell types. EMBO J. 10:1991;2821-2832.
135. Memon R.A., Feingold K.R., Grunfeld C. The effects of cytokines on intermediary metabolism. The Endocrinologist. 4:1994;59-63.
136. Merchav S., Tatarsky I., Hochberg Z. Enhancement of erythropoiesis in vitro by human growth hormone is mediated by insulin-like growth factor I. Brit. J. Hematol. 70:1988;267-271.
137. Merchav S., Tatarsky I., Hochberg Z. Enhancement of human granulopoiesis in vitro is mediated biosynthetic insulin-like growth factor-I/somatomedin C and human growth hormone. J. Clin. Invest. 81:1988;791-797.
138. Merchav S., Silvian-Drachsler I., Tatarsky I., Lake M., Skottner A. Comparative studies of the erythroid-potentiating effects of biosynthetic human insulin-like growth factors-I and -II. Endocrinology. 73:1992;447-452.
139. Merimee T.J., Grant M.B., Broder C.M., Cavalli-Sforza L.-L. Insulin-like growth factor secretion by human B-lymphocytes. a comparison of cells from normal and pygmy subjects J. Clin. Endocrinol. Metab. 69:1989;978-984.
140. Metcalf D., Nicola N. The hemopoietic colony-stimulating factors. From biology to clinical applications. 1995;University of Cambridge, New York, USA.
141. Minshall C., Liu Q., Arkins S., Kelley K.W. Growth hormone and immunology. Torosian M.H. Growth Hormone in Critical Illness - Research and Clinical Studies. 1995;159-184 R.G. Landes Company, Austin, TX.
142. Moltz H. Fever. causes and consequences Neurosci. Biobehav. Rev. 17:1993;237-269.
143. Murphy W.J., Tsarfaty G., Longo D.L. Growth hormone exerts hematopoietic growth-promoting effects in vivo and partially counteracts the myelosuppressive effects of azidothymidine. Blood. 80:1992;1443-1447.
144. Murphy W.J., Durum S.K., Longo D.L. Role of neuroendocrine hormones in murine T cell development. Growth hormone exerts thymopoietic effects in vivo. J. Immunol. 149:1992;3851-3857.
145. Murphy W.J., Durum S.K., Anver M.R., Longo D.L. Immunologic and hematologic effects of neuroendocrine hormones. Studies on DW/J dwarf mice. J. Immunol. 148:1992;3799-3805.
146. Murphy W.J., Durum S.K., Longo D.L. Human growth hormone promotes engraftment of murine or human T cells in severe combined immunodeficient mice. Proc. Natl. Acad. Sci. USA. 89:1992;4481-4485.
147. Murphy W.J., Durum S.K., Longo D.L. Differential effects of growth hormone and prolactin on murine T cell development and function. J. Exp. Med. 178:1993;231-236.
148. Muta K., Krantz S.B. Apoptosis of human erythroid colony-forming cells is decreased by stem cell factor and insulin-like growth factor I as well as erythropoietin. J. Cell. Physiol. 156:1993;264-271.
149. Navarra R.A., Tsagarakis S., Faria M.S., Rees L.H., Besser G.M., Grossman A.B. Interleukins-1 and -6 stimulate the release of corticotropin-releasing hormone-41 from rat hypothalamus in vitro via the eicosanoid cyclooxygenase pathway. Endocrinology. 128:1991;37-44.
150. Nonogaki K., Fuller G.M., Fuentes N.L., Moser A.H., Staprans I., Grunfeld C., Feingold K.R. Interleukin-6 stimulates hepatic triglyceride secretion in rats. Endocrinology. 136:1995;2143-2149.
151. Nophar Y., Kemper O., Brakebusch C. Soluble forms of tumor necrosis factor receptors (TNF-R-s). The cDNA for the type I TNF-R clones using amino acid sequence data of its soluble form, encodes both the cell surface and a soluble form of the receptor. EMBO J. 9:1990;3269-3275.
152. Oksenberg D., Dieckmann B.S., Greenberg P.L. Functional interactions between colony-stimulating factors and the insulin family hormones for human myeloid leukemic cells. Cancer Res. 50:1990;6471-6477.
153. Pahlman S., Meyerson G., Lindgren E., Schalling M., Johansson I. Insulin-like growth factor-I shifts from promoting cell division to potentiating maturation during neuronal differentiation. Proc. Natl. Acad. Sci. USA. 88:1991;9994-9998.
154. Parnet P., Brunke D.L., Goujon E., Mainard J.D., Biragyn A., Arkins S., Dantzer R., Kelley K.W. J. Neuroendocrinol. 5:1993;213-219.
155. Parnet P., Amindari S., Wu C., Brunke-Reese D., Goujon E., Weyhenmeyer J.A., Dantzer R., Kelley K.W. Expression of type I and type II interleukin-1 receptors in mouse brain. Mol. Brain Res. 27:1994;63-70.
156. Partanen J., Mäkela T.P., Alitalo R., Leshäslaiho H., Alitalo K. Putative tyrosine kinases expressed in K-562 human leukemia cells. Proc. Natl. Acad. Sci. USA. 87:1990;8913-8917.
157. Payne L.C., Weigent D.A., Blalock J.E. Induction of pituitary sensitivity to interleukin-1. a new function for corticotropin releasing hormone Biochem. Biophys. Res. Comm. 198:1994;480-484.
158. Peisen J.N., McDonnell K.J., Mulroney S.E., Lumpkin M.D. Endotoxin-induced suppression of the somatotropic axis is mediated by interleukin-1β and corticotropin-releasing factor in the juvenile rat. Endocrinology. 136:1995;3378-3390.
159. Perlstein R.S., Whitnall M.H., Abrams J.S., Mougey E.H., Neta R. Synergistic roles of interleukin-6, interleukin-1, and tumor necrosis factor in the adrenocorticotropin response to bacterial lipopolysaccharide in vivo. Endocrinology. 132:1993;946-952.
160. Phillips A.F., Persson B., Hall K., Lake M., Skottner A., Sanengen T., Sara V.R. The effects of biosynthetic insulin-like growth factor-I supplementation on somatic growth, maturation, and erythropoiesis in the neonatal rat. Pediatr. Res. 23:1988;298-305.
161. Plata-Salamán C.R. Meal patterns in response to the intracerebroventricular administration of interleukin-1β in rats. Physiol. Behav. 55:1994;727-733.
162. Plata-Salamán C.R., Oomura Y., Kai Y. Tumor necrosis factor and interleukin-1β suppression of food intake by direct action in the central nervous system Brain Res. 448:1988;106-114.
163. Prickett M.D., Latimer A.M., McCusker R.H., Hausman G.J., Prestwood A.K. Alterations of serum insulin-like growth factor-I (IGF-I) and IGF-binding proteins (IGFBPS) in swine infected with the protozoan parasite Sarcocystis miescheriana. Dom. Anim. Endocrinol. 9:1992;285-296.
164. Probert L., Keffer J., Carbella P., Cazlaris H., Patsavoudi E., Stephens S., Kaslaris E., Kioussis D., Kollias G. Wasting, ischemia, and lymphoid abnormalities in mice expressing T cell-targeted human tumor necrosis factor transgenes. J. Immunology. 151:1993;1894-1906.
165. Ratajczak M.Z., Kuczynski W.I., Onodera K., Moore J., Ratajczak J., Kregenow D.A., DeRiel K., Gewirtz A.M. A reappraisal of the role of insulin-like growth factor I in the regulation of human hematopoiesis. J. Clin. Invest. 94:1994;320-327.
166. Reiss K., Porcu P., Sell C., Pietrzkowski Z., Baserga R. The insulin-like growth factor-I receptor is required for proliferation of hemopoietic cells. Oncogene. 7:1992;2443-2448.
167. Renno T., Krakowski M., Piccirillo C., Lin J.-Y., Owens T. TNF-α expression by resident microglia and infiltrating leukocytes in the central nervous system of mice with experimental allergic encephalomyelitis. J. Immunology. 154:1995;944-953.
168. Resnicoff M., Abraham D., Yutanawiboonchai Y., Rotman H.L., Kajstura J., Rubin R., Zoltick P., Baserga R. The insulin-like growth factor I receptor protects tumor cells from apoptosis in vivo. Cancer Res. 55:1995;2463-2469.
169. Rivier C., Vale W., Brown M. In the rat, interleukin-1α and -β stimulate adrenocorticotropin and catecholamine release. Endocrinology. 125:1989;3096-3102.
170. Rivier C., Chizzonite R., Vale W. In the mouse, the activation of the hypothalamic-pituitary-adrenal axis by a lipopolysaccharide (endotoxin) is mediated through interleukin-1. Endocrinology. 125:1989;2800-2805.
171. Robbins K., McCabe S., Scheiner T., Strasser J., Clark R., Jardieu P. Immunological effects of insulin-like growth factor-I-enhancement of immunoglobulin synthesis. Clin. Exp. Immunol. 95:1994;337-342.
172. 2 synthesis by the stomach and retards gastric emptying. Life Sci. 48:1991;123-134.
173. Rodriguez-Tarduchy G., Collins M.K.L., Garcia I., Lopez-Rivas A. Insulin-like growth factor-I inhibits apoptosis in IL-3 dependent hemopoietic cells. J. Immunol. 149:1992;535-540.
174. Rudman D., Feller A.G., Nagraf H.S., Gergans G.A., Lalitha P.Y., Golberg A.F., Schlenker R.A., Cohn L., Rudman I.W. Effects of human growth hormone in men over 60 years old. N. Engl. J. Med. 323:1990;1-6.
175. Salmon W.D., Daughaday W.H. A hormonally controlled serum factor which stimulates sulphate incorporation by cartilage in vitro. J. Lab. Clin. Med. 49:1957;825-836.
176. Sanders M., Sorba S., Dainiak N. Insulin-like growth factors stimulate erythropoiesis in serum-substituted umbilical cord blood cultures. Exp. Hematol. 21:1993;25-30.
177. Saperas E.S., Yang H., Rivier C., Taché Y. Central action of interleukin-1 to inhibit acid secretion in rats. Gastroenterology. 99:1990;1599-1606.
178. Sara V.R., Hall K. Insulin-like growth factors and their binding proteins. Physiol. Rev. 70:1990;591-614.
179. Sato N., Miyajima A. Multimeric cytokine receptors. common versus specific functions Current Opinion in Cell Biol. 6:1994;174-179.
180. Scheven B.A.A., Hamilton N.J. Stimulation of macrophage growth and multinucleated cell formation in rat bone marrow cultures by insulin-like growth factor. Biochem. Bioph. Res. Comm. 174:1991;647-653.
181. Schöbitz B., Pezeshki G., Pohl T., Hemmann U., Heinrich P.C., Holsboer F., Reul J.M.H.M. Soluble interleukin-6 (IL-6) receptor augments central effects of IL-6 in vivo. FASEB J. 9:1995;659-664.
182. Schwartz G.N., Hudgins W.R., Perdue J.F. Glycosylated insulin-like growth factor-II promoted expansion of granulocyte-macrophage colony-forming cells in serum-deprived liquid cultures of human peripheral blood cells. Exp. Hematol. 21:1993;1447-1454.
183. Sharp A., Kukulansky T., Globerson A. In vitro analysis of age-related changes in the developmental potential of bone marrow thymocyte progenitors. Eur. J. Immunol. 20:1990;2541-2546.
184. Simoni M.G.D., Sironi M., Luigi A.D., Manfridi A., Mantovani A., Ghezzi P. Intracerebroventricular injection of interleukin 1 induces high circulating levels of interleukin 6. J. Exp. Med. 171:1990;1773-1778.
185. Simoni M.G.D., Del Bo R., De Luigi A., Simard S., Forloni G. Central endotoxin induces different patterns of interleukin (IL)-1β and IL-6 messenger ribonucleic acid expression and IL-6 secretion in the brain and periphery. Endocrinology. 136:1995;897-902.
186. Sims J.E., March C.J., Cosman D., Widmer M.B., Robson MacDonald H., McMahan C.J., Grubin C.E., Wignall J.M., Jackson J.L., Call S.M., Friend D., Alpert A.R., Gillis S., Urdal D.L., Dower S.K. DNA expression cloning of the IL-1 receptor, a member of the immunoglobulin superfamily. Science. 241:1988;585-589.
187. Sipponen P., Simila S., Collan Y., Autere T., Herva R. Familial syndrome with panhypopituitarism, hypoplasia of the hypophysis, and poorly developed sella turcica. Archiv. Dis. Childhood. 53:1978;664-667.
188. Skottner A., Clark R.G., Fryklund L., Robinson I. Growth responses in a mutant dwarf rat to human growth hormone and recombinant human insulin-like growth factor-I. Endocrinology. 124:1989;2519-2526.
189. Smith P.E. Effect of hypophysectomy upon the involution of the thymus in the rat. Anat. Rec. 47:1930;119-129.
190. Smith B.B., Wagner W.C. Suppression of prolactin in pigs by Escherichia coli endotoxin. Science. 224:1984;605-607.
191. Spitzer I.I., Bagby G.J., Meszaros K., Lang C.H. Altered control of carbohydrate metabolism in endotoxemia. Prog. Clin. Biol. Res. 286:1989;145-165.
192. Stith R.D., Templer L.A. Peripheral endocrine and metabolic responses to centrally administered interleukin-1. Neuroendocrinology. 60:1994;215-224.
193. Takao T., Tracey D.E., De Souza E.B. Interleukin-1 receptors in mouse brain. characterization and autoradiographic localization Endocrinology. 127:1990;3070-3078.
194. 125I]recombinant human interleukin-1 receptor antagonist. J. Neuroimmunol. 41:1992;51-60.
195. Tamemoto H., Kadowaki T., Tobe K., Yagi T., Sakura H., Hayakawa T., Terauchi Y., Ueki K., Kaburagi Y., Satoh S., Sekihara H., Yoshloka S., Horikoshi H., Furuta Y., Ikawa Y., Kasuga M., Yazaki Y., Aizawa S. Insulin resistance and growth retardation in mice lacking insulin receptor substrate-1. Nature. 372:1994;182-186.
196. Tapson V.F., Boni-Schnetzler M., Pilch P.F., Center D.M., Berman J.S. Structural and functional characterization of the human T lymphocyte receptor for insulin-like growth factor I in vitro. J. Clin. Invest. 82:1988;950-957.
197. Taub D.D., Tsarfaty G., Lloyd A.R., Durum S.K., Longo D.L., Murphy W.J. Growth hormone promotes human T cell adhesion and migration to both human and murine matrix proteins in vitro and directly promotes xenogeneic engraftment. J. Clin. Invest. 94:1994;293-300.
198. Tchelingerian J.-L., Quinonero J., Booss J., Jacque C. Localization of TNFα and IL-1α immunoreactivities in striatal neurons after surgical injury to the hippocampus. Neuron. 10:1993;213-224.
199. Terao A., Oikawa M., Saito M. Tissue-specific increase in norepinephrine turnover by central interleukin-1, but not by interleukin-6, in rats. Am. J. Physiol. 266:1994;R400-R404.
200. Tilders F.J.H., DeRijk R.H., van Dam A.M., Vincent V. A.M., Schotanus K., Persoons J.H.A. Activation of the hypothalamus-pituitary-adrenal axis by bacterial endotoxins. routes and intermediate signals Psychoneuroendocrinology. 19:1994;209-232.
201. Timsit J., Savino W., Safieh B., Chanson P., Gagnerault M.-C., Bach J.-F., Dardenne M. Growth hormone and insulin-like growth factor-I stimulate hormonal function and proliferation of thymic epithelial cells. J. Clin. Endocrinol. Metab. 75:1992;183-188.
202. Tracey K.J., Morgello S., Koplin B., Fahey T.J. III, Fox J., Aledo A., Manogue K.R., Cerami A. Metabolic effect of cachectin/tumor necrosis factor are modified by site of production. Cachectin/tumor necrosis factor-secreting tumor in skeletal muscle induces cachexia while implantation in the brain induces predominantly acute anorexia. J. Clin. Invest. 86:1990;2014-2024.
203. Underwood L.E. Growth hormone treatment, acromegaly, and relationship to cancer and leukemia. Bercu B.B., Walker R.F. Growth hormone II. 1993;259-268 Springer-Verlag, New York.
204. van der Meer M.J.M., Sweep C.G.J., Pesman G.J., Borm G.F., Hermus A.R.M.M. Synergism between IL-1β and TNF-α on the activity of the pituitary-adrenal axis and on food intake of rats. Am. J. Physiol. 268:1995;E551-E557.
205. Vriend C.Y., Zuo L., Dyck D.G., Nance D.M., Greenberg A.H. Central administration of interleukin-1β increases norepinephrine turnover in the spleen. Brain Res. Bull. 31:1993;39-42.
206. Wang L.-M., Myers M.G., Sun X.-J., Aaronson S.A., White M., Pierce J.H. IRS-1. essential for IL-4 stimulated mitogenesis in hematopoietic cells Science. 261:1993;1591-1594.
207. Wang X., Uhler M., Billestrup N., Norstedt G., Talamantes F., Nielsen J.H., Carter-Su C. Evidence for association of the cloned liver growth hormone receptor with a tyrosine kinase. J. Biol. Chem. 267:1992;17390-17396.
208. Watkins L.R., Wiertelak E.P., Goehler L.E., Mooney-Heiberger K., Martinez J., Furness L., Smith K.P., Maier S.F. Neurocircuitry of illness-induced hyperalgesia. Brain Res. 639:1994;283-299.
209. Watkins L.R., Wiertelak E.P., Goehler L.E., Smith K.P., Martin D., Maier S.F. Characterization of cytokine-induced hyperalgesia. Brain Res. 654:1994;15-26.
210. Weigent D.A., Blalock J.E., LeBoeuf R.D. An antisense oligodeoxynucleotide to growth hormone messenger ribonucleic acid inhibits lymphocyte proliferation. Endocrinology. 128:1991;2053-2057.
211. Weigent D.A., Blalock J.E. Associations between the neuroendocrine and immune systems. J. Leukoc. Biol. 57:1995;137-150.
212. Werner H., LeRoith D. Insulin-like growth factor I receptor. structure, signal transduction and function Diabetes Review. 3:1995;28-37.
213. Wexler B.C., Dolgin A.E., Tryczynski E.W. Effects of bacterial polysaccharide (piromen) on the pituitary-adrenal axis. adrenal ascorbic acid, cholesterol and histologic alterations Endocrinology. 61:1957;300-308.
214. Wexler B.C., Dolgin A.E., Tryczynski E.W. Effects of bacterial polysaccharide (piromen) on the pituitary-adrenal axis. further aspects of hypophyseal-mediated control of response Endocrinology. 61:1957;488-499.
215. White M.F., Maron R., Kahn C.R. Insulin rapidly stimulates tyrosine phosphorylation of a Mr-185,000 protein in intact cells. Nature. 318:1985;183-186.
216. White M.F., Kahn C.R. The insulin signaling system. J. Biol. Chem. 269:1994;1-4.
217. Weidermann C.J., Niedermuhlbichler M., Geissler D., Beimpold H., Braunsteiner H. Priming of normal human neutrophils by recombinant human growth hormone. Br. J. Haematol. 78:1991;19-22.
218. Williams G.T., Smith C.A., Spooncer E., Dexter T.M., Taylor D.R. Haemopoietic colony stimulating factors promote cell survival by suppressing apoptosis. Nature. 343:1990;76-79.
219. Woloski B.M., Smith E.M., Meyer W.J., Fuller G.M., Blalock J.E. Corticotropin-releasing activity of monokines. Science. 230:1985;1035-1037.
220. Yang Z.J., Koskeki M., Meguid M.M., Gleason J.R., Debonis D. Synergistic effect of rhTNF-α and rhIL-1α in inducing anorexia in rats. Am. J. Physiol. 267:1994;R1056-R1064.
221. Zamir O., Hasselgren P.O., Allmen D., Fischer J.E. In vivo administration of interleukin-1α induces muscle proteolysis in normal and adrenalectomized rats. Metabolism. 42:1993;204-208.
222. Zamir O., Hasselgren P.O., Kunkel S.L., Frederick J., Higashiguchi T., Fischer J.E. Evidence that tumor necrosis factor participates in the regulation of muscle proteolysis during sepsis. Arch. Surg. 127:1992;170-174.